S

Soleno Therapeutics
D

SLNO

86.550
USD
0.29
(0.34%)
مغلق
حجم التداول
16,619
الربح لكل سهم
-3
العائد الربحي
-
P/E
-18
حجم السوق
4,361,594,728
أصول ذات صلة
ABBV
ABBV
-1.530
(-0.80%)
189.200 USD
ALNY
ALNY
-4.39
(-1.33%)
325.26 USD
C
CRMD
0.045
(0.39%)
11.640 USD
G
GLPG
0.330
(1.16%)
28.870 USD
GSK
GSK
-0.285
(-0.74%)
38.220 USD
MRK
MRK
-1.370
(-1.66%)
81.010 USD
PFE
PFE
0.110
(0.43%)
25.440 USD
T
TTNP
0.07000
(1.65%)
4.32000 USD
المزيد
الأخبار المقالات

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.